Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RFXAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KMT2E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOSC6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSPH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UFM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTN2A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FMC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNMT3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NABP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM226B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
GALNT12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAMPT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BET1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSC22D1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GFI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MORC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on